Insights On Clinical Technologies

  1. New Duke Research Shows Participants Prefer Enhanced eConsent 10/7/2024

    It’s apparent to those who have used it that the “e” in eConsent could stand for much more than 'electronic'. Duke’s new research shows why participants prefer an eConsent experience bolstered with videos, media, questions, and more.

  2. Keeping Up With ClinOps: Why And How To Improve Delivery 11/6/2023

    Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.

  3. The Promise And Peril Of AI In Clinical Trials 7/16/2024

    In clinical research, as with many industries, AI is met with both excitement and trepidation. The impact of AI and machine learning is starting to be felt across the pharmaceutical industry.

  4. Navigating Regulatory And Privacy Updates In Clinical Trials 3/21/2025

    Explore how the guide for eRegulatory adoption in Canada provides resources to help stakeholders navigate these changes and enhance participant engagement and retention in clinical trials.

  5. Flexible Data Management For Growing Portfolio 7/31/2025

    Explore strategic enhancements to a small biopharma's biometrics capabilities involving the deployment of 20 specialized professionals, which effectively bolstered the client’s organizational capacity.

  6. Removing Chaos In 3 Steps: A Guide To Planning TMF Migrations 9/18/2023

    Knowledge and planning are the keys to successful trial master file migrations. Utilize this guide when navigating the most important part of any TMF migration: project scoping and planning.

  7. Insights From Pharma 2025: The Role Of Patient Journey 6/12/2025

    From predictive AI to the European Health Data Space, experts discuss how digital transformation is reshaping patient care, creating new pathways for commercial success in pharmaceuticals.

  8. Critical Imaging Risks In GLP-1 And Neurology Studies 5/27/2025

    As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

  9. Selecting Medidata Rave: A Testimonial From Richmond Pharmacology 4/25/2025

    What made the Medidata's Rave EDC system stand out to Richmond Pharmacology during their vendor selection period?

  10. Practical Approaches To Clinical Trial Diversity 9/9/2024

    Gain insights on FDA diversity action plans, and the important role that data points play in ensuring inclusion of underrepresented populations.